Barclays PLC Fennec Pharmaceuticals Inc. Transaction History

Barclays PLC

$353 Billion
Q1 2025

A detailed history of Barclays PLC transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Barclays PLC holds 24,301 shares of FENC stock, worth $197,324. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,301

Previous 35,672 31.88%

Holding current value

$197,324

Previous $225,000 34.22%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$5.54 - $7.02 $62,995 - $79,824	-11,371 Reduced 31.88%	24,301 $148,000
Q4 2024 Feb 13, 2025	BUY	$3.99 - $6.37 $17,368 - $27,728	4,353 Added 13.9%	35,672 $225,000
Q3 2024 Nov 15, 2024	BUY	$4.85 - $6.73 $111,312 - $154,460	22,951 Added 274.27%	31,319 $157,000
Q2 2024 Aug 14, 2024	SELL	$6.02 - $10.99 $27,138 - $49,542	-4,508 Reduced 35.01%	8,368 $52,000
Q1 2024 May 15, 2024	SELL	$8.82 - $11.12 $107,595 - $135,652	-12,199 Reduced 48.65%	12,876 $143,000
Q4 2023 Feb 15, 2024	BUY	$6.48 - $11.61 $140,065 - $250,950	21,615 Added 624.71%	25,075 $282,000
Q3 2023 Nov 07, 2023	SELL	$7.15 - $8.94 $1,251 - $1,564	-175 Reduced 4.81%	3,460 $26,000
Q2 2023 Aug 03, 2023	SELL	$7.27 - $9.82 $44,070 - $59,528	-6,062 Reduced 62.51%	3,635 $32,000
Q1 2023 May 04, 2023	BUY	$7.38 - $10.35 $3,225 - $4,522	437 Added 4.72%	9,697 $81,000
Q4 2022 Feb 13, 2023	BUY	$7.63 - $10.22 $70,653 - $94,637	9,260 New	9,260 $89,000
Q4 2021 Feb 14, 2022	SELL	$3.89 - $10.01 $10,300 - $26,506	-2,648 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$6.51 - $9.62 $2,252 - $3,328	-346 Reduced 11.56%	2,648 $25,000
Q2 2021 Aug 13, 2021	SELL	$5.96 - $7.85 $90,592 - $119,320	-15,200 Reduced 83.54%	2,994 $21,000
Q1 2021 May 13, 2021	BUY	$6.21 - $8.68 $69,365 - $96,955	11,170 Added 159.03%	18,194 $113,000
Q4 2020 Feb 11, 2021	SELL	$5.99 - $8.55 $16,646 - $23,760	-2,779 Reduced 28.35%	7,024 $53,000
Q3 2020 Nov 12, 2020	SELL	$5.19 - $10.17 $11,220 - $21,987	-2,162 Reduced 18.07%	9,803 $60,000
Q2 2020 Aug 12, 2020	BUY	$5.43 - $9.39 $64,969 - $112,351	11,965 New	11,965 $100,000
Q3 2019 Nov 14, 2019	SELL	$3.85 - $4.95 $2,090 - $2,687	-543 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$3.3 - $5.09 $9,480 - $14,623	-2,873 Reduced 84.1%	543 $2,000
Q1 2019 May 15, 2019	BUY	$4.64 - $7.58 $15,850 - $25,893	3,416 New	3,416 $17,000
Q4 2018 Feb 14, 2019	SELL	$5.37 - $8.39 $24,868 - $38,854	-4,631 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$7.84 - $10.83 $29,799 - $41,164	3,801 Added 457.95%	4,631 $38,000
Q2 2018 Aug 14, 2018	BUY	$10.05 - $14.33 $8,341 - $11,893	830 New	830 $8,000

Others Institutions Holding FENC

# of Institutions

Shares Held

13.9M

Call Options Held

10K

Put Options Held

83.8K

View Full List

About FENNEC PHARMACEUTICALS INC.

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $212M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

More about FENC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account